CONVALESCENT PLASMA THERAPY IN MODERATE TO SEVERE COVID-19 Faisal Muchtar1, Andi Adil1, Syafri Kamsul Arif1, Nasrum Massi2, Irawaty Djaharuddin3, Tutik Harjianti4, Hisbullah1, Nur Surya Wirawan1, Madonna D. Datu1, Haizah Nurdin1, Rusmin B. Syukur1
1Department of Anesthesiology, Intensive Care, and Pain Management, Faculty of Medicine, Hassanuddin University, Makassar, Indonesia
2Department of Microbiology, Faculty of Medicine, Hassanuddin University, Makassar, Indonesia
3Department of Pulmonology, Faculty of Medicine, Hassanuddin University, Makassar, Indonesia
4Department of Internal Medicine, Faculty of Medicine, Hassanuddin University, Makassar, Indonesia
Abstract
There has been ongoing research regarding the therapy for the new Coronavirus Disease 2019 (COVID-19) infection. Convalescent plasma therapy showed promising results in several cases of acute respiratory disease. We report 2 cases of patients with moderate to severe COVID-19 that was admitted with typical symptoms. In addition to supportive treatment, both patients were administered convalescent plasma during their hospitalization. The patient clinical features improved gradually without significant adverse effect. Both chest X-rays and laboratory examination also showed significant improvement.
